Chapter 23. Glucocorticoid-resistant asthma

Clinical and Experimental Allergy Reviews

Volumn 4, Issue SUPPL. 2, 2004, Pages 200-204

  Corrigan, C J ^a   Hawrylowicz, C M ^a   Lavender, P ^a   Lee, T H ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Asthma; Glucocorticoid; Resistance; Therapy

Indexed keywords

CYTOKINE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HISTONE; INTERLEUKIN 10; INTERLEUKIN 5; PREDNISOLONE; REGULATOR PROTEIN;

ACETYLATION; ASTHMA; COMPLEX FORMATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; DISEASE SEVERITY; DNA STRUCTURE; GLUCOCORTICOID RESISTANT ASTHMA; HUMAN; LIGAND BINDING; PHOSPHORYLATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 11844292781     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-9725.2004.00055.x     Document Type: Conference Paper

References (43)

1. Woolcock AJ. Steroid-resistant asthma: what is the clinical definition? Eur Respir J 1993; 6:743-7.
2. Schwartz HL, Lowell FC, Melby JC. Steroid resistance in bronchial asthma. Ann Intern Med 1968; 69:493-9.
3. Carmichael J, Paterson IC, Diaz P et al. Corticosteroid resistance in chronic asthma. Br Med J 1981; 282:1419-22.
4. Alvarez J, Surs W, Leung DYM et al. Steroid resistant asthma: immunologic and pharmacologic features. J Allergy Clin Immunol 1992; 89:714-21.
5. Lee TH, Brattsand R, Leung D. Corticosteroid action and resistance in asthma. Am J Respir Crit Care Med 1996; 154:S51.
6. Corrigan CJ, Kay AB. The role of T lymphocytes and eosinophils in the pathogenesis of asthma. Immunol Today 1992; 13:501-7.
7. Corrigan CJ, Hamid Q, North J et al. Peripheral blood CD4 but not CD8 T-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a TH2-type pattern: effect of glucocorticoid therapy. Am J Respir Cell Mol Biol 1995; 12:567-78.
8. Corrigan CJ, Brown PH, Barnes NC et al. Glucocorticoid resistance in chronic asthma: glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics and inhibition of peripheral blood T-cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 1991; 144:1016-25.
9. Corrigan CJ, Brown PH, Barnes NC et al. Glucocorticoid resistance in chronic asthma: peripheral blood T-lymphocyte activation and a comparison of the T-lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Respir Dis 1991; 144:1026-32.
10. Haczku A, Alexander A, Brown P et al. The effect of dexamethasone, cyclosporine and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma. J Allergy Clin Immunol 1994; 93:510-9.
11. Spahn JD, Leung DY, Surs W et al. Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation. Am J Respir Crit Care Med 1995; 151: 1709-14.
12. Sher ER, Leung DM, Surs W et al. Steroid-resistant asthma: cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 1994; 93:33-9.
13. Kam JC, Szefler SJ, Surs W et al. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 1993; 151:3460-6.
14. Spahn JD, Szefler SJ, Surs W et al. A novel action of IL-13: induction of reduced monocyte glucocorticoid receptor-binding affinity. J Immunol 1996; 157:2654-9.
15. Leung DY, Martin RJ, Szefler SJ et al. Dysregulation of interleukin 4, interleukin-5 and interferon gamma gene expression in steroid-resistant asthma. J Exp Med 1995; 181:33-40.
16. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. IL-10 and the IL-10 receptor. Annu Rev Immunol 2001; 19:683-765.
17. Wan S, DeSmet JM, Antoine M et al. Steroid administration in heart and heart-lung transplantation: is the timing adequate? Ann Thoracic Surg 1996; 61:674-8.
18. John M, Lim S, Seybold J et al. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med 1998; 157:256-62.
19. + T cell differentiation towards a phenotype with high IL-10 and reduced IL-4, IL-5 and IL-13 production. Eur J Immunol 2000; 30:2344-54.
20. Borish L, Aarons A, Rumbyrt J et al. Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 1996; 97:1288-96.
21. Lim S, Crawley E, Woo P, Barnes PJ. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 1998; 352:113.
22. Hawrylowicz CM, Richards DF, Loke T-K, Corrigan CJ, Lee TH. A defect in corticosteroid-induced IL-10 production in T lymphocytes from corticosteroid resistant asthmatic patients. J Allergy Clin Immunol 2002; 109:369-70.
23. + T cells is induced by immunosuppressive drugs and inhibited by Th1 and Th2-inducing cytokines. J Exp Med 2002; 195:603-16.
24. Reichhardt HM, Tuckermann JP, Gottlicher M et al. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J 2001; 20:7168-73.
25. English JM, Cobb MH. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci 2002; 23:40-5.
26. Adcock IM, Lane SJ, Brown CR et al. Defective binding of glucocorticoid receptor to DNA in steroid-resistant asthma. J Immunol 1995; 154:3500-5.
27. Adcock IM, Lane SJ, Brown CR et al. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. J Exp Med 1995; 182:1951-8.
28. Lane SJ, Adcock IM, Richards D et al. Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes. J Clin Invest 1998; 102:2156-64.
29. Irusen E, Matthews JG, Takatiashi A et al. p38 MAP kinase-induced glucocorticoid-receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J Allergy Clin Immunol 2002; 109:649-57.
30. Oakley RH, Sar M, Cidlowski JA. The human glucocorticoid receptor β isoform: expression, biochemical properties, and putative function. J Biol Chem 1996; 271:9550-9.
31. Bledsoe RK, Montana VG, Stanley TB et al. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerisation and coactivator recognition. Cell 2002; 110:93-105.
32. Oakley RH, Jewell CM, Yudt MR et al. The dominant negative activity of the human glucocorticoid receptor β isoform. J Biol Chem 1999; 274:27857-66.
33. Webster JC, Oakley RH, Jewell CM, Cidlowski JA. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β-isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci USA 2001; 98:6865-70.
34. Strickland I, Kisich K, Hauk PJ et al. High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J Exp Med 2001; 193:585-94.
35. Hamid QA, Wenzel SE, Hank PJ et al. Increased glucocorticoid receptor β in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 1999; 159:1600-4.
36. Sousa AR, Lane SJ, Cidlowski JA et al. Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform. J Allergy Clin Immunol 2000; 105:943-50.
37. Imhof A, Wolffe AP. Transcription: gene control by targeted histone acetylation. Curr Biol 1998; 8:R422-R424.
38. Bertos NR, Wang AH, Yang XJ. Class II histone deacetylases: structure, function and regulation. Biochem Cell Biol 2001; 79:243-52.
39. Smith et al. J Immunol 2001; 167:2502-10.
40. Ito K, Lim S, Caramori G et al. Cigarette smoking reduces histone deacetylase2 expression, enhances cytokine expression and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001; 15:1110-2.
41. Lane SJ, Arm JP, Staynov DZ et al. Chemical mutational analysis of the human glucocorticoid receptor cDNA in glucocorticoid-resistant bronchial asthma. Am J Respir Cell Mol Biol 1994; 11:42-8.
42. Lamberts SWJ, Huizenga ATM, de Lande P et al. Clinical aspects of glucocorticoid sensitivity. Steroids 1996; 147:690-6.
43. Hall IP. Genetic factors in asthma severity. Clin Exp Allergy 1998; 28 (5 Suppl.):16-20.